Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Factors influencing medical staff's intentions to implement family-witnessed cardiopulmonary resuscitation: A cross-sectional, multihospital survey.

Chen CL, Tang JS, Lai MK, Hung CH, Hsieh HM, Yang HL, Chuang CC.

Eur J Cardiovasc Nurs. 2017 Aug;16(6):492-501. doi: 10.1177/1474515117692663. Epub 2017 Feb 13.

PMID:
28756694
2.

Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia.

Lee JH, Francis PT, Ballard CG, Aarsland D, Kalaria RN, Wong PT, Chen CP, Lai MK.

J Parkinsons Dis. 2016 Oct 19;6(4):733-739.

PMID:
27662332
3.

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy.

Wang YJ, Huang CY, Hou WH, Wang CC, Lan KH, Yu HJ, Lai MK, Liu SP, Pu YS, Cheng JC.

Oncotarget. 2016 Jul 12;7(28):44224-44235. doi: 10.18632/oncotarget.10000.

4.

The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer.

Wang YJ, Huang CY, Hou WH, Wang CC, Lan KH, Chen CH, Yu HJ, Lai MK, Cheng AL, Liu SP, Pu YS, Cheng JC.

World J Surg Oncol. 2015 Nov 6;13:312. doi: 10.1186/s12957-015-0721-4.

5.

Does varicocele grade predict the postoperative changes of semen parameters following left inguinal micro-varicocelectomy?

Wang H, Wang X, Fu D, Zhu H, Lai MK.

Asian J Urol. 2015 Jul;2(3):163-166. doi: 10.1016/j.ajur.2015.07.002. Epub 2015 Jul 13.

6.

Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: experience from an Asian tertiary referral center.

Tai HC, Lai MK, Huang CY, Wang SM, Huang KH, Chen CH, Chung SD, Chueh SC, Yu HJ, Pu YS.

J Endourol. 2014 Feb;28(2):165-71. doi: 10.1089/end.2013.0118. Epub 2013 Oct 17.

PMID:
23987245
7.

Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.

Pu YS, Huang CY, Chen JY, Kang WY, Lin YC, Shiu YS, Chuang SJ, Yu HJ, Lai MK, Tsai YC, Wu WJ, Hour TC.

J Biomed Sci. 2012 Apr 5;19:39. doi: 10.1186/1423-0127-19-39.

8.

Long-term oncologic outcomes of hand-assisted retroperitoneoscopic radical nephrectomy to treat clinically localized renal cell carcinoma.

Hung SF, Wang SM, Chung SD, Lai MK, Huang KH, Pu YS, Yu HJ, Huang CY.

J Formos Med Assoc. 2012 Jan;111(1):41-5. doi: 10.1016/j.jfma.2012.01.002. Epub 2012 Feb 2.

9.

Smoking is associated with poor self-rated health among adolescents in Hong Kong.

Wang MP, Ho SY, Lo WS, Lai MK, Lam TH.

Nicotine Tob Res. 2012 Jun;14(6):682-7. doi: 10.1093/ntr/ntr266. Epub 2011 Dec 16.

PMID:
22180586
10.

Oncologic outcomes of asian men with clinically localized prostate cancer after extraperitoneal laparoscopic radical prostatectomy: a single-institution experience.

Tai HC, Lai MK, Huang CY, Wang SM, Huang KH, Chung SD, Chueh SC, Yu HJ.

Prostate Cancer. 2011;2011:748616. doi: 10.1155/2011/748616. Epub 2010 Dec 19.

11.

Novel inanimate training model for urethrovesical anastomosis in laparoscopic radical prostatectomy.

Chung SD, Tai HC, Lai MK, Huang CY, Wang SM, Tsai YC, Chueh SC, Liao CH, Yu HJ.

Asian J Surg. 2010 Oct;33(4):188-92. doi: 10.1016/S1015-9584(11)60005-5.

12.

Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.

Aisa B, Gil-Bea FJ, Solas M, García-Alloza M, Chen CP, Lai MK, Francis PT, Ramírez MJ.

J Alzheimers Dis. 2010;20(2):659-68. doi: 10.3233/JAD-2010-1398.

13.

Cadmium burden and the risk and phenotype of prostate cancer.

Chen YC, Pu YS, Wu HC, Wu TT, Lai MK, Yang CY, Sung FC.

BMC Cancer. 2009 Dec 10;9:429. doi: 10.1186/1471-2407-9-429.

14.

Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy.

Tsai CL, Wu JK, Wang CW, Hsu FM, Lai MK, Cheng JC.

Strahlenther Onkol. 2009 Sep;185(9):588-95. doi: 10.1007/s00066-009-1987-7. Epub 2009 Sep 12.

PMID:
19756425
15.

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma.

Pu YS, Huang CY, Kuo YZ, Kang WY, Liu GY, Huang AM, Yu HJ, Lai MK, Huang SP, Wu WJ, Chiou SJ, Hour TC.

J Biomed Sci. 2009 Sep 12;16:82. doi: 10.1186/1423-0127-16-82.

16.

An audit of nephroureterectomy for upper tract urothelial carcinoma.

Huang CY, Chung SD, Wang SM, Liao CH, Lai MK, Huang KH, Pu YS, Chueh SC, Yu HJ.

Eur J Surg Oncol. 2009 Dec;35(12):1333-6. doi: 10.1016/j.ejso.2009.05.010. Epub 2009 Jul 5.

PMID:
19581070
17.
18.

Long-term outcome of hand-assisted laparoscopic nephroureterectomy for pathologic T3 upper urinary tract urothelial carcinoma.

Chung SD, Chen SC, Wang SM, Chueh SC, Lai MK, Huang CY, Pu YS, Huang KH, Yu HJ.

J Endourol. 2009 Jan;23(1):75-80. doi: 10.1089/end.2008.0267.

PMID:
19178172
19.
20.
21.

An alternative access technique under direct vision for preperitoneoscopic pelvic surgery: easier for the beginners.

Tai HC, Lai MK, Chueh SC, Chen SC, Hsieh MH, Yu HJ.

Ann Surg Oncol. 2008 Sep;15(9):2589-93. doi: 10.1245/s10434-008-9883-4. Epub 2008 Jun 19.

PMID:
18563490
22.

Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease.

Marcos B, García-Alloza M, Gil-Bea FJ, Chuang TT, Francis PT, Chen CP, Tsang SW, Lai MK, Ramirez MJ.

J Alzheimers Dis. 2008 May;14(1):43-50.

23.

Comparison between hand-assisted laparoscopic and retroperitoneoscopic nephroureterectomy for the management of upper urinary tract urothelial carcinoma: analysis of an intermediate follow-up period.

Chung SD, Chueh SC, Huang CY, Lai MK, Pu YS, Yu HJ, Huang KH.

Surg Laparosc Endosc Percutan Tech. 2008 Feb;18(1):49-53. doi: 10.1097/SLE.0b013e318159e84b.

PMID:
18287983
24.

Laparoscopic adrenalectomy using needlescopic instruments for adrenal tumors less than 5cm in 112 cases.

Liao CH, Lai MK, Li HY, Chen SC, Chueh SC.

Eur Urol. 2008 Sep;54(3):640-6. doi: 10.1016/j.eururo.2007.12.028. Epub 2007 Dec 26.

PMID:
18164803
25.

Long-term outcome of hand-assisted laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: comparison with open surgery.

Chung SD, Chueh SC, Lai MK, Huang CY, Pu YS, Yu HJ, Huang KH.

J Endourol. 2007 Jun;21(6):595-9.

PMID:
17638552
26.
27.

Long-term follow-up of hand-assisted laparoscopic radical nephrectomy for organ-confined renal cell carcinoma.

Chung SD, Huang KH, Lai MK, Huang CY, Pu YS, Yu HJ, Chueh SC.

Urology. 2007 Apr;69(4):652-5.

PMID:
17445645
28.

High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.

Huang PC, Huang CY, Huang SW, Lai MK, Yu HJ, Chen J, Pu YS.

Int J Urol. 2006 Jul;13(7):864-9.

29.

Expanding the donor pool: use of renal transplants from non-heart-beating donors supported with extracorporeal membrane oxygenation.

Lee CY, Tsai MK, Ko WJ, Chang CJ, Hu RH, Chueh SC, Lai MK, Lee PH.

Clin Transplant. 2005 Jun;19(3):383-90.

PMID:
15877803
30.

Use of Hem-o-lok clips effectively lengthens renal vein during laparoscopic live donor nephrectomy.

Chueh SC, Wang SM, Lai MK.

Transplant Proc. 2004 Nov;36(9):2623-4.

PMID:
15621106
31.

Clipless needlescopic bilateral varix ligation.

Chueh SC, Liao CH, Wang SM, Hsieh MH, Lai MK, Chen J.

J Androl. 2005 Jan-Feb;26(1):93-7.

PMID:
15611572
32.

The utility of resistance index of distal interlobular arteries in evaluating renal graft function.

Wang SM, Lai MK, Chueh SC, Chen J.

Transplant Proc. 2004 Sep;36(7):2184-5.

PMID:
15518794
33.

Catechins prevents substance P-induced hyperactive bladder in rats via the downregulation of ICAM and ROS.

Chen WC, Hayakawa S, Shimizu K, Chien CT, Lai MK.

Neurosci Lett. 2004 Sep 2;367(2):213-7.

PMID:
15331156
34.
35.

Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions.

Chueh SC, Lai MK, Liu IS, Teng FC, Chen J.

Transplant Proc. 2003 Jun;35(4):1603-5.

PMID:
12826232
36.

Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS.

Chien CT, Yu HJ, Lin TB, Lai MK, Hsu SM.

Am J Physiol Renal Physiol. 2003 Apr;284(4):F840-51.

37.
38.

Clipless laparoscopic adrenalectomy with needlescopic instruments.

Chueh SC, Chen J, Chen SC, Liao CH, Lai MK.

J Urol. 2002 Jan;167(1):39-42; discussion 42-3.

PMID:
11743271
39.

Use of polymerase chain reaction to detect Proteus mirabilis and Ureaplasma urealyticum in urinary calculi.

Huang HS, Chen J, Teng LJ, Lai MK.

J Formos Med Assoc. 1999 Dec;98(12):844-50.

PMID:
10634025
40.

High-frequency oscillatory ventilation in premature infants.

Lai MK, Jeng MJ, Soong WJ, Liu CW, Chen SJ, Hwang B.

Zhonghua Yi Xue Za Zhi (Taipei). 1999 Dec;62(12):879-85.

PMID:
10634002
41.

Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.

Pu YS, Liu CM, Kao JH, Chen J, Lai MK.

Eur Urol. 1999 Oct;36(4):293-7.

PMID:
10473987
42.

Differential expression of type 1 angiotensin II receptor mRNA and aldosterone responsiveness to angiotensin in aldosterone-producing adenoma.

Chen YM, Wu KD, Hu-Tsai MI, Chu JS, Lai MK, Hsieh BS.

Mol Cell Endocrinol. 1999 Jun 25;152(1-2):47-55.

PMID:
10432222
43.

Penile cancer in Taiwan--20 years' experience at National Taiwan University Hospital.

Chiu TY, Huang HS, Lai MK, Chen J, Hsieh TS, Chueh SC.

J Formos Med Assoc. 1998 Oct;97(10):673-8.

PMID:
9830276
44.

Megestrol acetate antagonizes cisplatin cytotoxicity.

Pu YS, Cheng AL, Chen J, Guan JY, Lu SH, Lai MK, Hsieh CY.

Anticancer Drugs. 1998 Sep;9(8):733-8.

PMID:
9823432
45.

High prevalence of voiding symptoms in Taiwanese women.

Yu HJ, Chen J, Lai MK, Chan KA, Chie WC.

Br J Urol. 1998 Oct;82(4):520-3.

PMID:
9806180
46.

Post-renal transplant erythrocytosis.

Chien HC, Huang CC, Huang JY, Chu SH, Lai MK.

Changgeng Yi Xue Za Zhi. 1996 Sep;19(3):235-40.

PMID:
8921641
47.

Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.

Pu YS, Tsai TC, Cheng AL, Tsai CY, Tseng NF, Su IJ, Hsieh CY, Lai MK.

J Urol. 1996 Jul;156(1):271-5.

PMID:
8648821
48.

Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.

Pu YS, Hsieh TS, Cheng AL, Tseng NF, Su IJ, Hsieh CY, Lai MK, Tsai TC.

Br J Urol. 1996 Jan;77(1):76-85.

PMID:
8653321
49.

Tamoxifen enhances the chemosensitivity of bladder carcinoma cells.

Pu YS, Hsieh TS, Tsai TC, Cheng AL, Hsieh CY, Su IJ, Lai MK.

J Urol. 1995 Aug;154(2 Pt 1):601-5.

PMID:
7609145
50.

Urologic cancers in uremic patients.

Chen KS, Lai MK, Huang CC, Chu SH, Leu ML.

Am J Kidney Dis. 1995 May;25(5):694-700.

PMID:
7747722

Supplemental Content

Loading ...
Support Center